Asthma and Pulmonary dis.

chemical mediators of inflammation stored and released by mast cells; effects are similar to those of histamine

chemical derivative of caffeine; alternative bronchodilators, prescribed for persistent chronic asthma.

device used to convert a solid drug to a fine powder for the purpose of inhalation

recurrent disease of the lungs characterized by excess mucus production, inflammation, and coughing

generic term used to describe several pulmonary conditions characterized by cough, mucus production, and impaired gas exchange

acts by selectively binding to the beta 2 adrenergic receptors in bronchial smooth muscles to cause bronchodialation. can prevent exercise induced bronchospasms. Better suited for tx of chronic asthma due to it's duration. onset 10-20mins, duration up to 12hrs.

anticholinergic that causes bronchodilation by blocking cholinergic receptors in bronchial smooth muscle. also prescribed for chronic bronchitis and nasal congestion. onset 5-15 mins, duration 3-6 hrs. bitter taste, rinse mouth,

glucocorticoid, available thru aerosol inhalation (MDI) for asthma or as a nasal spray for allergic rhinitis. Acts by reducing inflammation, decreasing frequency of asthma attacks.

used for the prophylaxis of persistent, chronic asthma. Blocks leukotrine receptors in the airways. onset 1 wk. adverse effects most common HA.

suspension of minute liquid droplets or fine solid particles suspended in a gas- delivers the drugs to their immediate site of action (immediate relief for bronchospasms)

most commonly used for treating pulmonary disorders, stimulate beta 2 adrenergic receptors to dilate bronchioles

use a propellant to deliver a mesuared dose of drug to the lungs during each breath. disadvantages- precise does received difficult to measure

beta-adrenergic agonists- activate both beta 1 and 2 receptors (severent)

oral medications approved for the prophylaxis of chronic asthma- reduce inflammation and ease bronchoconstriction